TNFSF10 and Miyoshi myopathy: Other reports tried to understand how Suberoylanilide Hydroxamic Acid (SAHA), a histone deacetylase inhibitor (HDAC), might enhance the effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) [66] in MM cells.